Litcius/Paper detail

Are the benefits of SGLT2 inhibitors in heart failure and a reduced ejection fraction influenced by background therapy? Expectations and realities of a new standard of care

Milton Packer

2020European Heart Journal27 citationsDOIOpen Access PDF

Topics & Concepts

MedicineEjection fractionHeart failureStandard of careIntensive care medicineCardiologyInternal medicineFraction (chemistry)ChemistryOrganic chemistryDiabetes Treatment and ManagementHeart Failure Treatment and ManagementAdenosine and Purinergic Signaling
Are the benefits of SGLT2 inhibitors in heart failure and a reduced ejection fraction influenced by background therapy? Expectations and realities of a new standard of care | Litcius